Published within
| Type |
Product title / description
|
Pub
|
Price |
Expert View
|
The Israeli wealth market may only be the 30th largest in the world, but the penetration of HNWs in the adult population and a growing propensity to deposit money in Switzerland mean Israeli HNWs are of increasing significance for Swiss wealth managers. As a result, more Swiss banks are opening up onshore operations in Israel, with media reports suggesting Pictet & Cie will soon follow suit.
Published By Datamonitor
|
26 Oct 2012 |
|
Expert View
|
UBS has opened a wealth management and investment house in Israel, offering domestic and international investment management services. The decision follows an in-depth market analysis that identified the country as a promising market in terms of wealth growth. Israel's resilient economy and its robust financial system are expected to attract further players to the market in the next few years.
Published By Datamonitor
|
07 Mar 2012 |
|
CommentWire
|
Teva's laquinimod has failed to meet its primary Phase III endpoint of reducing annualized relapse rate. This is a blow for Teva and development partner Active Biotech, as the drug was on track to become the next oral disease-modifying therapy available for multiple sclerosis (MS). However, hope remains for the drug's potential in Crohn's disease and lupus, for which Phase II trials are ongoing.
Published By Datamonitor
|
02 Aug 2011 |
|
CommentWire
|
Woolworths and Coles, the "big two" in Australian grocery retailing, have been named, shamed, and fined for incorrectly labeling imported produce as "local." While Australians are generally keen to support their local community, violations such as these threaten to weaken the local movement. At a time when rising food prices are already putting pressure on local offerings, authenticity is key.
Published By Datamonitor
|
18 May 2011 |
|
CommentWire
|
Cubist Pharmaceuticals has granted Teva a non-exclusive license to launch a generic version of its antibiotic Cubicin in the US. The move brings the dispute - which had been running since 2009 - to a close, and eliminates the risk of Cubist losing Cubicin sales in the event of Teva winning the patent litigation.
Published By Datamonitor
|
08 Apr 2011 |
|
CommentWire
|
The discovery of natural gas deposits beneath the Eastern Mediterranean has shifted the outlook for Israel's energy market. It is thought that the reserves hold enough gas to feed Israel's consumption for decades, and may even turn the energy-dependent country into an exporter. However, the discovery has served to exacerbate political tensions, and further development faces major challenges.
Published By Datamonitor
|
06 Sep 2010 |
|
CommentWire
|
CF101, an orally-available TNF-alpha antagonist, has shown promising results in a Phase IIa study for the treatment of moderate to severe psoriasis. With current therapies focused on topical agents and biologics, this interesting oral compound has potential benefits for an unmet need in the treatment of psoriasis.
Published By Datamonitor
|
09 Sep 2009 |
|
Expert View
|
Having established themselves in the European market, edge IPK and Earnix are expanding into the US property and casualty market. Both vendors have compelling offerings that should succeed in the US market, however, new regulations in the US insurance market and cost restrictions brought on by the current economic climate will not make it easy for either company.
Published By Datamonitor
|
10 Jul 2009 |
|
Expert View
|
Meal options targeted at singles have been somewhat limited in the past, with most packaged foods catering for families or couples. A Norwegian store aims to change this by offering singles more choice, with a selection of limited edition meat cuts especially portioned for the singles market. As more people are living on their own, the singles market could become a bigger target in future.
Published By Datamonitor
|
20 Feb 2009 |
|
Expert View
|
The growing health trend has seen the release of an array of niche products, as a look at the latest launches on Productscan reveals. One such product is a new bottled water that has been created especially for diabetics, highlighting how drinks manufacturers attempt to get ahead of the competition by offering something different.
Published By Datamonitor
|
18 Jan 2008 |
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.